Disparate effects of two phosphatidylcholine binding proteins, C-reactive protein and surfactant protein A, on pulmonary surfactant structure and function

被引:16
作者
Nag, K
Rodriguez-Capote, K
Panda, AK
Frederick, L
Hearn, SA
Petersen, NO
Schurch, S
Possmayer, F [1 ]
机构
[1] Univ Western Ontario, Dept Chem, London, ON N6A 5A5, Canada
[2] Univ Western Ontario, Dept Obstet, London, ON N6A 5A5, Canada
[3] Univ Western Ontario, Dept Gynecol, London, ON N6A 5A5, Canada
[4] Univ Western Ontario, Canadian Inst Hlth Res Grp Fetal & Neonatal Hlth, London, ON N6A 5A5, Canada
[5] Univ Western Ontario, St Josephs Hlth Ctr, Dept Pathol, London, ON N6A 4V2, Canada
[6] Univ Calgary, Dept Physiol & Biophys, Calgary, AB T2N 4N1, Canada
[7] Havana Inst Ciencias Basicas & Preclin Victoria G, Dept Bioquim, Inst Super Ciencias Med, Havana, Cuba
[8] Behala Coll, Dept Chem, Kolkata 700060, W Bengal, India
关键词
acute respiratory distress syndrome; captive bubble tensiometer; electron microscopy; surface tension; surfactant biophysical impairment;
D O I
10.1152/ajplung.00408.2003
中图分类号
Q4 [生理学];
学科分类号
071003 ;
摘要
C-reactive protein (CRP) and surfactant protein A (SP-A) are phosphatidylcholine (PC) binding proteins that function in the innate host defense system. We examined the effects of CRP and SP-A on the surface activity of bovine lipid extract surfactant (BLES), a clinically applied modified natural surfactant. CRP inhibited BLES adsorption to form a surface-active film and the film's ability to lower surface tension (gamma) to low values near 0 mN/m during surface area reduction. The inhibitory effects of CRP were reversed by phosphorylcholine, a water-soluble CRP ligand. SP-A enhanced BLES adsorption and its ability to lower gamma to low values. Small amounts of SP-A blocked the inhibitory effects of CRP. Electron microscopy showed CRP has little effect on the lipid structure of BLES. SP-A altered BLES multilamellar vesicular structure by generating large, loose bilayer structures that were separated by a fuzzy amorphous material, likely SP-A. These studies indicate that although SP-A and CRP both bind PC, there is a difference in the manner in which they interact with surface films.
引用
收藏
页码:L1145 / L1153
页数:9
相关论文
共 61 条
[1]   REVERSIBLE AND IRREVERSIBLE INACTIVATION OF PREFORMED PULMONARY SURFACTANT SURFACE-FILMS BY CHANGES IN SUBPHASE CONSTITUENTS [J].
AMIRKHANIAN, JD ;
TAEUSCH, HW .
BIOCHIMICA ET BIOPHYSICA ACTA, 1993, 1165 (03) :321-326
[2]   Phosphatidylcholine molecular species in lung surfactant - Composition in relation to respiratory rate and lung development [J].
Bernhard, W ;
Hoffmann, S ;
Dombrowsky, H ;
Rau, GA ;
Kamlage, A ;
Kappler, M ;
Haitsma, JJ ;
Freihorst, J ;
von der Hardt, H ;
Poets, CF .
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 2001, 25 (06) :725-731
[3]  
BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911
[4]  
CAPOTE KR, 2001, AM J PHYSIOL-LUNG C, V281, pL231
[5]   Increase of C-reactive protein and decrease of surfactant protein a in surfactant after lung transplantation [J].
Casals, C ;
Varela, A ;
Ruano, MLF ;
Valiño, F ;
Pérez-Gil, J ;
Torre, N ;
Jorge, E ;
Tendillo, F ;
Castillo-Olivares, JL .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1998, 157 (01) :43-49
[6]   C-reactive protein binds to both oxidized LDL and apoptotic cells through recognition of a common ligand: Phosphorylcholine of oxidized phospholipids [J].
Chang, MK ;
Binder, CJ ;
Torzewski, M ;
Witztum, JL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (20) :13043-13048
[7]   EFFECT OF SURFACTANT-ASSOCIATED PROTEIN-A (SP-A) ON THE ACTIVITY OF LIPID EXTRACT SURFACTANT [J].
CHUNG, J ;
YU, SH ;
WHITSETT, JA ;
HARDING, PGR ;
POSSMAYER, F .
BIOCHIMICA ET BIOPHYSICA ACTA, 1989, 1002 (03) :348-358
[8]   PULMONARY SURFACTANT-ASSOCIATED PROTEIN-A ENHANCES THE SURFACE-ACTIVITY OF LIPID EXTRACT SURFACTANT AND REVERSES INHIBITION BY BLOOD PROTEINS INVITRO [J].
COCKSHUTT, AM ;
WEITZ, J ;
POSSMAYER, F .
BIOCHEMISTRY, 1990, 29 (36) :8424-8429
[9]  
Dong Q, 1996, J IMMUNOL, V156, P4815
[10]   Pulmonary surfactant:: functions, abnormalities and therapeutic options [J].
Frerking, I ;
Günther, A ;
Seeger, W ;
Pison, U .
INTENSIVE CARE MEDICINE, 2001, 27 (11) :1699-1717